Current Cancer Drug Targets

Editor-in-Chief:

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
USA

Back



Meet Our Editorial Board Member: free to download

Volume:16   Issue:4
Pp: 287-287
Evan Keller
DOI: 10.2174/156800961604160408203704

Targeted Inhibition of Rictor/mTORC2 in Cancer Treatment: A New Era after Rapamycin

Volume:16   Issue:4
Pp: 288-304
Zhipeng Zou, Juan Chen, Jun Yang and Xiaochun Bai
DOI: 10.2174/1568009616666151113120830

New Insights into the Molecular Resistance Mechanisms of Chronic Myeloid Leukemia

Volume:16   Issue:4
Pp: 323-345
Rui Huang, Qian Kang, Huimin Liu and Yuhua Li
DOI: 10.2174/1568009615666150921141004

Development of Linker-Conjugated Nanosize Lipid Vesicles: A Strategy for Cell Selective Treatment in Breast Cancer

Volume:16   Issue:4
Pp: 357-372
Niladri Shekhar Dey, Biswajit Mukherjee, Ruma Maji and Bhabani Sankar Satapathy
DOI: 10.2174/1568009616666151106120606

Epigallocatechin-3-gallate Increases RXRγ-mediated Pro-apoptotic and Anti-invasive Effects in Gastrointestinal Cancer Cell Lines

Volume:16   Issue:4
Pp: 373-385
Alessio Papi, Marzia Govoni, Carmen Ciavarella, Enzo Spisni, Marina Orlandi and Fulvia Farabegoli
DOI: 10.2174/1568009615666150817120931